Please use this identifier to cite or link to this item:
|Title:||Erratum to: Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines|
|Authors:||Kaiser, Peter K.|
Cruess, Alan F.
Kelly, Simon P.
|Citation:||Graefe's Archive for Clinical and Experimental Ophthalmology, February 2013, 251 (2), pp 625-626|
|Abstract:||Erratum to: Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines|
|Rights:||Copyright © the authors, 2013. This is an open-access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Description:||This Erratum relates to http://hdl.handle.net/2381/37322|
|Appears in Collections:||Published Articles, College of Medicine, Biological Sciences and Psychology|
Files in This Item:
|art%3A10.1007%2Fs00417-012-2230-2.pdf||Erratum||73.52 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.